Walleye Capital’s Sharps Compliance Corp SMED Stock Holding History

Walleye Capital’s Portfolio SMED Stock Details SMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,700	Closed	-$131	–	1959
2021 Q2	$131	Buy	+12,700	New	+$177K	﹤0.01%	1133

Other funds holding SMED

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Walleye Capital's SMED Position: Q3 2021 in Review

Walleye Capital sold out of Sharps Compliance Corp (SMED) in Q3 2021, closing a stake of 12,700 shares — an estimated $131 sold.

Walleye Capital first reported a position in SMED in Q2 2021 and held it in 1 quarter. The position peaked at $131 in Q2 2021. 79 funds tracked by Wall St. Rank hold SMED as of Q3 2021.

Walleye Capital reported no remaining Sharps Compliance Corp position as of Q3 2021 after selling out during the quarter.
Walleye Capital sold 12,700 Sharps Compliance Corp shares in Q3 2021, an estimated $131.
Walleye Capital first reported a position in Sharps Compliance Corp in Q2 2021 and held it in 1 quarter.
Walleye Capital's Sharps Compliance Corp position peaked at $131 in Q2 2021.
79 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2021.

Based on Walleye Capital's 13F filing for Q3 2021, filed 15 Nov 2021.